Abstract:Background: A nationwide campaign for rational proton pump inhibitor (PPI) use launched in 2015 had a positive impact for hospitalized patients PPI use. But there were few studies focusing on the rational use of PPIs in outpatients. In 2018, the PPI management committee conducted a year-long intervention on the appropriate use of PPIs in outpatient and emergency departments, including clinical pharmacist interventions and stewardship interventions. The purpose of this study was to examine the impact of the PPI management committee's multifaceted interventions by comparing the real-world acid suppressant prescribing patterns for outpatients before (2017) and after intervention (2019) at a Chinese tertiary teaching hospital. Methods: Prescriptions containing any acid suppressant in outpatient and emergency departments in baseline (2017) and postintervention (2019) periods were extracted from the hospital information system and the prescription automatic screening system. Acid suppressant prescribing patterns were evaluated based on primary diagnoses and patient demographics. The prescribed acid suppressants stratified using age groups (< 7, 7-17, 18-45, 46-65, 66-85 and > 85 years) were also examined. Result: The utilization rate of acid suppressant in 2017 and 2019 was 2.5% (41,165/1,619,366) and 2.2% (49,550/2,236,471), respectively (P < 0.0001). 60,135 acid suppressant prescriptions were obtained in 2017 and 73,275 in 2019. The rate of acid suppressant prescriptions for the approved indications significantly increased from 62.6% (2017) to 65.4% (2019) (P < 0.0001). Prescriptions diagnosed as abnormal symptoms, signs and clinical manifestations, decreased in 2019 (13.0% vs. 16.5%, P < 0.0001). The most frequently prescribed PPIs differed between 2017 and 2019 (rabeprazole 2017 vs. esomeprazole 2019). Omeprazole was the most common PPI and cimetidine was the most common H2RA prescribed to patients aged < 18 years in 2017 and 2019. A total of CNY11.83 million was spent on acid suppressants in 2019, accounting for about 48.7% of total medication cost, increased by 11.3% from 2017 (37.4%). Conclusion: The proportion of acid suppressant prescriptions for approved indications was enhanced after the PPI management committee's multifaceted interventions, but there were still some problems in the selection of acid suppressants.

Utilization of Proton Pump Inhibitors in a Hospital During the Period of 2008-2010

Retrospective Comments on Prescriptions of Oral Proton Pump Inhibitors for Outpatients in A General Hospital

Analysis on The Use of Oral Proton Pump Inhibitors in The Inpatients of Peking University Shenzhen Hospital During 2009-2011

Analysis of the clinical use of proton pump inhibitors of six cities around Yangtze River Basin from 2009 to 2011

Optimization of Hospital Drug Management Model under the Supervision of Internet Plus Medical Health

Effectiveness of Continuous Improvement by a Clinical Pharmacist-Led Guidance Team on the Prophylactic Antibiotics Usage Rationality in Intervention Procedure at a Chinese Tertiary Teaching Hospital

Comparison of the Use of Hypoglycemic Drugs in Our Hospital Between 1996 and 2001

Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China:a multicentre cross-sectional study

Impact of proton pump inhibitor management committee's multifaceted interventions on acid suppressant prescribing patterns in outpatient and emergency departments

Utilization of the Digestive System Drugs in Our Hospital During the Period 2008-2009

Clinical Application of Proton Pump Inhibitors

Analysis of Use of Chinese Traditional Patent Drugs in a 3A Grade Hospital during 2005—2007

Utilization of Chinese Patent Medicines in Our Hospital

Off Label Use of Proton Pump Inhibitors and Economic Burden in Chinese Population: A Retrospective Analysis Using Claims Database

Utilization of the Oral Stasis-eliminating Chinese Patent Medicines in Our Hospital During 2006～2008

Analysis of Utilization of Chinese Patent Medicine in Shanghai Yangpu District Central Hospital During 2009-2011

Impact on Hospital Medicine After Adjusting the Drug Pricing Method

Rationale use of proton pump inhibitors: Observational study of hospital based prescriptions and role of clinical pharmacist

Brand Name and Generic Proton Pump Inhibitor Prescriptions in the United States: Insights from the National Ambulatory Medical Care Survey (2006–2010)

Utilization of Antibiotics in Our Hospital During 2007～2008

Standardized evaluation about single-disease clinical pathway on perioperative use of proton pump inhibitors in a grade 2 and first-class hospital